MYC and neoplasm: Ma and colleagues identified MYC as a negative regulator that impeded the migratory and invasive capacity mediated by Ras and Lgl and decreased expression of the JNK signaling target, matrix metalloproteinase (MMP-1) [339], thereby interfering with tumor migration and metastasis [339].